I will take this bait as well. KZA mismanaged to the hilt. ummmmYou must mean using the ATM platform that was not even out of the woods in terms of preclinical data but was advertised with trial starting dates which built in false value.....hang on that was not the new management that was the old.
You must mean finding the new delivery for idronoxil in late 2012 and not telling one NRT investor of the discovery......no wait that was the old as well. Or you must mean starting trials without any evaluated IP then being challenged and having to hand over 5% of your company to another......or wait that is not even KZA management. You must mean those huge salary package for Heaton and Brown.....no wait that was old management as well .
Ummmm perhaps you are referring to bringing to the company a phase II trial (GDC-084) for a mere 7.5M cash plus only milestone payments on successful steps forward instead of spending well in excess of 150M just to get us to a phase I trial with cantrixil. Yeah shame on JG
Or perhaps you are talking about the new collaborations with this new drug. Yeah JG is such a loser for starting another trial to save kids
Or perhaps you are talking about facing up to the truth about the ATM platform. Yeah JG such a tosser for being honest.
Or perhaps you are talking about slashing wages and costs.
Or perhaps you just have no idea. Yeah that makes more sense.
